101 related articles for article (PubMed ID: 1584960)
1. Activity of ornithine decarboxylase (ODC) and polyamine levels as biochemical markers of malignancy in human brain tumors.
Ernestus RI; Röhn G; Schröder R; Klug N; Hossmann KA; Paschen W
Acta Histochem Suppl; 1992; 42():159-64. PubMed ID: 1584960
[TBL] [Abstract][Full Text] [Related]
2. Polyamine metabolism in brain tumours: diagnostic relevance of quantitative biochemistry.
Ernestus RI; Röhn G; Schröder R; Els T; Klekner A ; Paschen W; Klug N
J Neurol Neurosurg Psychiatry; 2001 Jul; 71(1):88-92. PubMed ID: 11413269
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase activity in human brain tumors.
Röhn G; Ernestus RI; Schröder R; Hossmann KA; Klug N; Paschen W
Acta Histochem Suppl; 1992; 42():155-8. PubMed ID: 1350103
[TBL] [Abstract][Full Text] [Related]
4. Polyamine levels of human colorectal adenocarcinomas are correlated with tumor stage and grade.
Weiss TS; Bernhardt G; Buschauer A; Thasler WE; Dolgner D; Zirngibl H; Jauch KW
Int J Colorectal Dis; 2002 Nov; 17(6):381-7. PubMed ID: 12355213
[TBL] [Abstract][Full Text] [Related]
5. [Ornithine decarboxylase activity and polyamine levels in human thyroid tumor tissue].
Yamamoto O
Nihon Geka Gakkai Zasshi; 1989 Jul; 90(7):1049-56. PubMed ID: 2796972
[TBL] [Abstract][Full Text] [Related]
6. Polyamine metabolism in gliomas.
Ernestus RI; Röhn G; Schröder R; Els T; Lee JY; Klug N; Paschen W
J Neurooncol; 1996 Aug; 29(2):167-74. PubMed ID: 8858522
[TBL] [Abstract][Full Text] [Related]
7. Degrees of malignancy in human primary central nervous system tumors: ornithine decarboxylase levels as better indicators than adenosylmethionine decarboxylase levels.
Scalabrino G; Modena D; Ferioli ME; Puerari M; Luccarelli G
J Natl Cancer Inst; 1982 May; 68(5):751-4. PubMed ID: 6951085
[TBL] [Abstract][Full Text] [Related]
8. Ornithine decarboxylase and polyamines in colorectal neoplasia and mucosa.
Hixson LJ; Garewal HS; McGee DL; Sloan D; Fennerty MB; Sampliner RE; Gerner EW
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):369-74. PubMed ID: 8348060
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters.
Cañizares F; Salinas J; de las Heras M; Diaz J; Tovar I; Martinez P; Peñafiel R
Clin Cancer Res; 1999 Aug; 5(8):2035-41. PubMed ID: 10473083
[TBL] [Abstract][Full Text] [Related]
10. Regional distribution of ornithine decarboxylase activity and polyamine levels in experimental cat brain tumors.
Röhn G; Els T; Hell K; Ernestus RI
Neurochem Int; 2001 Aug; 39(2):135-40. PubMed ID: 11408092
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma.
Arrieta O; Garcia E; Guevara P; Garcia-Navarrete R; Ondarza R; Rembao D; Sotelo J
Cancer; 2002 Jun; 94(12):3210-8. PubMed ID: 12115353
[TBL] [Abstract][Full Text] [Related]
12. Degree of enhancement of polyamine biosynthetic decarboxylase activities in human tumors: a useful new index of degree of malignancy.
Scalabrino G; Ferioli ME
Cancer Detect Prev; 1985; 8(1-2):11-6. PubMed ID: 4064029
[TBL] [Abstract][Full Text] [Related]
13. Levels of colorectal ornithine decarboxylase activity in patients with colon cancer, a family history of nonpolyposis hereditary colorectal cancer, and adenomas.
Love RR; Surawicz TS; Morrissey JF; Verma AK
Cancer Epidemiol Biomarkers Prev; 1992; 1(3):195-8. PubMed ID: 1306105
[TBL] [Abstract][Full Text] [Related]
14. [Ornithine decarboxylase activity and polyamine content in human adenocarcinomas of the stomach and large intestine].
Berdinskikh NK; Zaletok SP; Bobro LI; Ignatenko NA
Eksp Onkol; 1988; 10(6):39-41. PubMed ID: 3243193
[TBL] [Abstract][Full Text] [Related]
15. [Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis].
Nakagawa H; Kubo S; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
No Shinkei Geka; 1991 Dec; 19(12):1135-41. PubMed ID: 1766538
[TBL] [Abstract][Full Text] [Related]
16. Ornithine decarboxylase and polyamines in familial adenomatous polyposis.
Giardiello FM; Hamilton SR; Hylind LM; Yang VW; Tamez P; Casero RA
Cancer Res; 1997 Jan; 57(2):199-201. PubMed ID: 9000553
[TBL] [Abstract][Full Text] [Related]
17. Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase.
Slotkin TA; Seidler FJ; Trepanier PA; Whitmore WL; Lerea L; Barnes GA; Weigel SJ; Bartolome J
J Pharmacol Exp Ther; 1982 Sep; 222(3):741-5. PubMed ID: 6809932
[TBL] [Abstract][Full Text] [Related]
18. Colonic polyamine content and ornithine decarboxylase activity as markers for adenomas.
McGarrity TJ; Peiffer LP; Bartholomew MJ; Pegg AE
Cancer; 1990 Oct; 66(7):1539-43. PubMed ID: 2208006
[TBL] [Abstract][Full Text] [Related]
19. Early developmental profile of ornithine decarboxylase in the frog, Microhyla ornata and its regulation by polyamines.
Joseph K; Baby TG
J Exp Zool; 1991 May; 258(2):158-63. PubMed ID: 2022946
[TBL] [Abstract][Full Text] [Related]
20. Ornithine decarboxylase: an unreliable marker for the identification of population groups at risk for colonic neoplasia.
Braverman DZ; Stankiewicz H; Goldstein R; Patz JK; Morali GA; Jacobsohn WZ
Am J Gastroenterol; 1990 Jun; 85(6):723-6. PubMed ID: 2353692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
